News

Boussard & Gavaudan Holding Limited: Latest NAV Update

Boussard & Gavaudan Holding Limited: Latest NAV Update

Boussard & Gavaudan Holding Limited Overview

Boussard & Gavaudan Holding Limited is a well-known closed-ended investment company recognized within the finance industry for its effective management strategies. This article provides recent updates on the company's net asset value (NAV) and market activities.

Estimated NAV Information

The Directors of Boussard & Gavaudan Holding Limited are excited to present important updates concerning the company's valuation. As of the latest business close on September 13, the estimated NAV is as follows:

Estimated NAV

  • Euro Shares: € 28.5840
  • Sterling Shares: £ 25.6401

Monthly and Yearly Returns

Investors can monitor performance through the estimated returns detailed below:

  • Estimated MTD Return: -0.48%
  • Estimated YTD Return: 3.76%
  • Estimated ITD Return: 185.84%

Keep in mind that these returns have been calculated after accounting for management and performance fees.

Market Information

Understanding current market conditions helps shareholders and potential investors make informed decisions:

  • Market Close for Euro Shares: € 27.20
  • Premium/Discount to Estimated NAV: -4.84%

Sterling Shares Market Status

The market status for Sterling Shares is as follows:

  • Market Close: GBX 2,260.00
  • Premium/Discount to Estimated NAV: -11.86%

Recent Transactions in Own Securities

Boussard & Gavaudan Holding Limited has engaged in transactions involving its ordinary shares. Here’s a summary of the recent activities:

Ordinary Shares Transactions

  • Number of Shares: N/A
  • Average Price: N/A
  • Range of Price: N/A

Liquidity Enhancement Agreement Insights

The liquidity enhancement agreement outlines several metrics related to share availability:

  • Number of Shares: N/A
  • Average Price: N/A

BGHL Capital - Key Information

It's essential for stakeholders to understand the capitalization of Boussard & Gavaudan Holding Limited:

  • Shares Outstanding: Euro Shares: 12,299,516 | Sterling Shares: 123,090
  • Shares Issued: 12,299,516 (Euro Shares) & 123,090 (Sterling Shares)

Estimated BG Fund NAV

If you're interested in how the BG Fund is performing, here are the estimates:

  • Class B Euro Shares: € 258.1322
  • Class GBP A Shares: £ 137.3698

It’s important to note that the Class B Euro Shares of the BG Fund don't incur investment manager fees, which could result in potentially higher returns.

Contact Information

If you need more information, feel free to contact Boussard & Gavaudan Investment Management, LLP:

Emmanuel Gavaudan
+44 (0) 20 3751 5389
Email: info@bgam-uk.com

Frequently Asked Questions

What does NAV stand for in investment terms?

NAV stands for Net Asset Value, which reflects the total value of a company's assets after subtracting its liabilities.

What are the estimated returns for Euro Shares?

The estimated returns for Euro Shares include a MTD return of -0.48% and a YTD return of 3.76%.

Where can I find the shares of BGHL?

The shares of Boussard & Gavaudan Holding Limited are available on Euronext Amsterdam and the London Stock Exchange.

What is the current market close for Sterling Shares?

The current market close for Sterling Shares stands at GBX 2,260.00.

Who should I reach out to for more information about BGHL?

You can get in touch with Emmanuel Gavaudan at Boussard & Gavaudan Investment Management, LLP for any inquiries related to BGHL.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

3TREES Debuts Green Coatings to East African Market

Updated Category News Views 56

3TREES Rocks East Africa's Construction Scene Nairobi's got a spark this week, and it's radiating straight from 3TREES' corner at the Big 5 Construct Kenya. With the Sarit Expo Centre buzzing from October 21, 2026, this Chinese company didn't just show up—they made one hell of an entrance. Presenting eco-friendly coating solutions, they pushed the 'Create Healthy Life'...

Continue Reading
PNCC Strengthens Network with Oculeus Anti-Fraud Tech

Updated Category News Views 10

Palau might not be on everyone's investing radar, but it should be if you're tracking the telecommunication industry in unique locales. The Palau National Communications Corporation (PNCC) has made a strategic move by deploying the Oculeus Anti-Fraud System (AFS) to safeguard its subscribers and commercial operations against the ever-present and sneaky threats of telecom...

Continue Reading
Henlius Reports Strong Outcomes in U.S. Serplulimab Study

Updated Category News Views 0

Henlius has got tongues wagging with some hefty news out of their recent ASTRIDE trial. They've chalked up some promising results in terms of survival for folks staring down Extensive-Stage Small Cell Lung Cancer (ES-SCLC). Now, in the perennial footrace between science and disease, this is one of those rare moments where you feel like science might just pull ahead—for...

Continue Reading
Touchmark's Q3 Bonanza: Income Leaps 39%, Stock Repurchase

Updated Category News Views 205

Ever seen a bank juggle financials like a street performer with flaming torches? That's Touchmark Bancshares for you this quarter. This Georgia-based community bank just released their third quarter 2026 results, and it seems they've not only mastered performance but also pranced around market risks effortlessly, much to the delight of investors. Breaking Down the Numbers...

Continue Reading
Compal and ARC Cloud Forge AI Partnership

Updated Category News Views 49

AI Infrastructure: A New Era of Collaboration Well, here's one that's got my old trader veins throbbing with excitement. Compal Electronics and ARC Cloud are shaking hands in a deal that could sketch out a bold new chapter in AI infrastructure. This ain't your run-of-the-mill tech announcement; it's a strategic dance aimed at supercharging the very backbone of large-scale...

Continue Reading
DIRECTV and DAZN: NBA Games Reach Local Fans

Updated Category News Views 53

DIRECTV Teams Up With DAZN: A Slam Dunk for NBA Fans DIRECTV just inked a deal with DAZN to broadcast games for five NBA teams—Cleveland Cavaliers, Indiana Pacers, Memphis Grizzlies, Minnesota Timberwolves, and San Antonio Spurs—across their territories. For fans, this means a whole lot more hoops action conveniently bundled into your TV package, right in your living...

Continue Reading
Sanctuary Medicinals Opens New Saugus Dispensary with a Bang

Updated Category News Views 137

Saugus Gets a New Neighbor: Sanctuary Medicinals October 30th is shaping up to be quite the spectacle in Saugus, Massachusetts, with Sanctuary Medicinals pulling out all the stops for their Halloween-themed Grand Opening. This is more than just a new dispensary popping up—it's a little celebration of the community they've become a part of. So, if you thought cannabis...

Continue Reading
Implantica's Strategic U.S. Entry with RefluxStop®

Updated Category News Views 0

Implantica's Ambitious Move into the U.S. Market Every now and then, a move in the medtech sector grabs everyone's attention, and that's what we got with Implantica's latest play. This company is pulling out the big guns to push its RefluxStop® device into the U.S. market—one of the toughest nuts to crack. They've roped in Dr. John C. Lipham, a leading U.S. surgeon, to...

Continue Reading
Vertiv's SmartIT: The New AI Infrastructure Game-Changer

Updated Category News Views 108

Taking AI Infrastructure Up a Notch Vertiv Holdings Co. (NYSE: VRT) is charging ahead with a solution that's bound to rattle the cages of status quo infrastructure deployments. Say hello to Vertiv™ SmartIT, a finely-tuned piece of kit that's pre-engineered to ease up the often painful process of high-density AI deployments across various environments—from homey...

Continue Reading
HIMS Lawsuit: Investors Under the Gun Before Deadline

Updated Category News Views 71

HIMS Investors Find Themselves in Hot Water Well, it looks like the ball's in your court, folks. Hims & Hers Health, Inc. (NYSE: HIMS) has been caught in a whirlwind of legal drama, and if you're holding any $HIMS stock, you've got some decisions to make—and fast. With a looming November 2 deadline to step up in a securities class action, this is one of those...

Continue Reading

Top 5 Most Recently Viewed Articles

NN, Inc.'s Q3 2024 Financial Performance Analysis

Updated Category News Views 115

NN, Inc. Highlights Third Quarter 2024 Results NN, Inc. (NASDAQ: NNBR), a leader in engineering high-precision industrial component manufacturing, has recently shared its financial performance results for the third quarter ending September 30, 2024. This exciting release encompasses key metrics that showcase the company's ongoing transformation and growth strategies. Key...

Continue Reading
Short Shorts Film Festival & Asia 2024 Autumn Screening Launch

Updated Category News Views 314

Short Shorts Film Festival: A Glimpse into Global Storytelling The Short Shorts Film Festival & Asia 2024 is set to be a grand spectacle, serving as a vivid canvas for over 60 award-winning shorts from around the globe. This isn't just any film festival—it's where creativity meets cultural depth. The lineup includes the Grand-Prix winners and other special selections...

Continue Reading
Eyal Feldman Honored as One of the Top CEOs of 2024

Updated Category News Views 228

Eyal Feldman Recognized as a Leading CEO for 2024 Eyal Feldman, the CEO and co-founder of Stampli, has made quite a mark in the business world by being named #10 on Comparably's Best CEOs of 2024 list. This recognition highlights not only his leadership capabilities but also the thriving culture at Stampli. Throughout 2024, the company has garnered multiple awards for its...

Continue Reading
WELL Health Secures Major Stake in HEALWELL AI for Growth

Updated Category News Views 413

WELL Health's Strategic Investment in HEALWELL AI WELL Health Technologies Corp. (TSX: WELL) is preparing for a significant advancement in the digital healthcare landscape by amending its call right to acquire a majority controlling interest in HEALWELL AI. This strategic move aligns with HEALWELL's impending acquisition of Orion Health, marking a transformative phase for...

Continue Reading
Honda Motor Co. Reports Strong Growth in Q1 Financials

Updated Category News Views 102

Overview of Q1 Financial Results Honda Motor Co., Ltd. (HMC:NYSE) recently disclosed its consolidated financial results for the fiscal first quarter. The results underline a positive trajectory with significant growth in both the motorcycle and automobile sectors. Key Financial Metrics For the quarter ended June 30, the operating profit reached 244.1 billion yen, which...

Continue Reading